These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2676432)

  • 1. Meaningful degrees of prevention or improvement of nerve conduction in controlled clinical trials of diabetic neuropathy.
    Dyck PJ; O'Brien PC
    Diabetes Care; 1989 Oct; 12(9):649-52. PubMed ID: 2676432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of nerve conduction studies with diabetic neuropathy symptom score and diabetic neuropathy examination score in type-2 diabetics for detection of sensorimotor polyneuropathy.
    Asad A; Hameed MA; Khan UA; Butt MU; Ahmed N; Nadeem A
    J Pak Med Assoc; 2009 Sep; 59(9):594-8. PubMed ID: 19750851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycemic control and nerve conduction abnormalities in non-insulin-dependent diabetic subjects.
    Graf RJ; Halter JB; Pfeifer MA; Halar E; Brozovich F; Porte D
    Ann Intern Med; 1981 Mar; 94(3):307-11. PubMed ID: 7013592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross sectional study to evaluate the effect of duration of type 2 diabetes mellitus on the nerve conduction velocity in diabetic peripheral neuropathy.
    Hussain G; Rizvi SA; Singhal S; Zubair M; Ahmad J
    Diabetes Metab Syndr; 2014; 8(1):48-52. PubMed ID: 24661759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlations between nerve function and tissue oxygenation in diabetic patients: further clues to the aetiology of diabetic neuropathy?
    Young MJ; Veves A; Walker MG; Boulton AJ
    Diabetologia; 1992 Dec; 35(12):1146-50. PubMed ID: 1478366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Interrelationship among nerve conduction velocity, amplitudes of compound muscle and compound nerve action potentials in diabetic neuropathy].
    Hasegawa O; Matsumoto S; Iino M; Mori I; Arita T; Baba Y
    No To Shinkei; 1999 Oct; 51(10):863-6. PubMed ID: 10553586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The diagnostic accuracy of Neuropad for assessing large and small fibre diabetic neuropathy.
    Ponirakis G; Petropoulos IN; Fadavi H; Alam U; Asghar O; Marshall A; Tavakoli M; Malik RA
    Diabet Med; 2014 Dec; 31(12):1673-80. PubMed ID: 24975286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diabetic neuropathy. Study of motor conduction velocity in the cubital and peroneal nerves].
    Palaó Sanchez A
    Arch Neurobiol (Madr); 1971; 34(5):399-410. PubMed ID: 5117544
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of H-reflex latency studies in the diagnosis of subclinical diabetic neuropathy.
    Marya RK; Chandran AP; Maini BK; Gupta RR
    Indian J Physiol Pharmacol; 1986; 30(2):133-8. PubMed ID: 3818039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Subclinical lesions of peripheral nervous system in multiple sclerosis patients].
    Pogorzelski R; Baniukiewicz E; Drozdowski W
    Neurol Neurochir Pol; 2004; 38(4):257-64. PubMed ID: 15383952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy of tolrestat in the treatment of diabetic peripheral neuropathy. A meta-analysis of individual patient data.
    Nicolucci A; Carinci F; Graepel JG; Hohman TC; Ferris F; Lachin JM
    Diabetes Care; 1996 Oct; 19(10):1091-6. PubMed ID: 8886554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Femoral versus peroneal neuropathy in diabetic children and adolescents--relationships to clinical status, metabolic control and retinopathy.
    Kruger M; Brunko E; Dorchy H; Noël P
    Diabete Metab; 1987 Apr; 13(2):110-5. PubMed ID: 3595967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of TGF-β1 in patients of diabetic peripheral neuropathy and its correlation with nerve conduction velocity in type 2 diabetes mellitus.
    Hussain G; Rizvi SA; Singhal S; Zubair M; Ahmad J
    Diabetes Metab Syndr; 2016; 10(1 Suppl 1):S135-9. PubMed ID: 26559756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in nerve conduction velocity after six weeks of glucoregulation with portable insulin infusion pumps.
    Pietri A; Ehle AL; Raskin P
    Diabetes; 1980 Aug; 29(8):668-71. PubMed ID: 7002680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of polyneuropathy severity in chronic renal failure patients on continuous ambulatory peritoneal dialysis or on maintenance hemodialysis].
    Janda K; Stompór T; Gryz E; Szczudlik A; Drozdz M; Kraśniak A; Sułowicz W
    Przegl Lek; 2007; 64(6):423-30. PubMed ID: 18159852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of atrophy of foot muscles in diabetic neuropathy -- a comparative study of nerve conduction studies and ultrasonography.
    Severinsen K; Andersen H
    Clin Neurophysiol; 2007 Oct; 118(10):2172-5. PubMed ID: 17709290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Median and ulnar nerve conduction measurements in patients with symptoms of diabetic peripheral neuropathy using the NC-stat system.
    Vinik AI; Emley MS; Megerian JT; Gozani SN
    Diabetes Technol Ther; 2004 Dec; 6(6):816-24. PubMed ID: 15684634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restoring lower limb blood flow improves conduction velocity in diabetic patients.
    Young MJ; Veves A; Smith JV; Walker MG; Boulton AJ
    Diabetologia; 1995 Sep; 38(9):1051-4. PubMed ID: 8591818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simplified electrodiagnostic criteria of diabetic polyneuropathy in field study (KCIS No. 14).
    Hsu WC; Chiu YH; Chen WH; Chiu HC; Liou HH; Chen TH
    Neuroepidemiology; 2007; 28(1):50-5. PubMed ID: 17215587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hereditary motor-sensory neuropathy. II. Electrophysiological studies].
    Ryniewicz B; Nowak-Michalska T; Badurska B; Jedrzejowska H; Drac H
    Neurol Neurochir Pol; 1986; 20(2):95-100. PubMed ID: 3464849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.